{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:52:59Z","timestamp":1789149179059,"version":"build-2803163510"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12016-021-08836-7","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T11:08:34Z","timestamp":1611832114000},"page":"416-428","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Leveraging Genetics for Hereditary Angioedema: A Road Map to Precision Medicine"],"prefix":"10.1007","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3315-6947","authenticated-orcid":false,"given":"Anastasios E.","family":"Germenis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-4952","authenticated-orcid":false,"given":"Matija","family":"Rijavec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9565-1911","authenticated-orcid":false,"given":"Camila Lopes","family":"Veronez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"key":"8836_CR1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.iac.2017.04.001","volume":"37","author":"AP Kaplan","year":"2017","unstructured":"Kaplan AP, Joseph K (2017) Pathogenesis of hereditary angioedema: the role of the BK-forming cascade. Immunol Allergy Clin North Am 37:513\u2013525","journal-title":"Immunol Allergy Clin North Am"},{"key":"8836_CR2","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/cea.13506","volume":"49","author":"M Margaglione","year":"2019","unstructured":"Margaglione M, D\u2019Apolito M, Santocroce R, Bruna Maffione A (2019) Hereditary angioedema: looking for BK production and triggers of vascular permeability. Clin Exp Allergy 49:1395\u20131402","journal-title":"Clin Exp Allergy"},{"key":"8836_CR3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(00)02483-1","volume":"356","author":"K Bork","year":"2000","unstructured":"Bork K, Barnstedt S, Koch P, Traupe H (2000) Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 356:213\u2013217","journal-title":"Lancet"},{"key":"8836_CR4","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1067\/mai.2000.108106","volume":"106","author":"K Binkley","year":"2000","unstructured":"Binkley K, Davis AE III (2000) Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol 106:546\u2013550","journal-title":"J Allergy Clin Immunol"},{"key":"8836_CR5","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.bbrc.2006.03.092","volume":"343","author":"G Dewald","year":"2006","unstructured":"Dewald G, Bork K (2006) Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun 343:1286\u20131289","journal-title":"Biochem Biophys Res Commun"},{"key":"8836_CR6","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/509899","volume":"79","author":"S Cichon","year":"2006","unstructured":"Cichon S, Martin L, Hennies HC, M\u00fcller F, Van Driessche K, Karpushova A, Stevens W et al (2006) Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am J Hum Genet 79:1098\u20131104","journal-title":"Am J Hum Genet"},{"key":"8836_CR7","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/all.12714","volume":"70","author":"M Speletas","year":"2015","unstructured":"Speletas M, Szil\u00e1gyi \u00c1, Csuka D, Koutsostathis N, Psarros F, Moldovan D, Magerl M et al (2015) F12\u201346C\/T polymorphism as modifier of the clinical phenotype of hereditary angioedema. Allergy 70:1661\u20131664","journal-title":"Allergy"},{"key":"8836_CR8","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/cea.13470","volume":"49","author":"M Rijavec","year":"2019","unstructured":"Rijavec M, Ko\u0161nik M, Andrejevi\u0107 S, Karad\u017ea-Lapi\u0107 L, Griv\u010deva-Panovska V, Koro\u0161ec P (2019) The functional promoter F12\u201346C\/T variant predicts the asymptomatic phenotype of C1-INH-HAE. Clin Exp Allergy 49:1520\u20131522","journal-title":"Clin Exp Allergy"},{"key":"8836_CR9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/07853890.2018.1449959","volume":"50","author":"V Griv\u010deva-Panovska","year":"2018","unstructured":"Griv\u010deva-Panovska V, Ko\u0161nik M, Koro\u0161ec P, Andrejevi\u0107 S, Karad\u017ea-Lapi\u0107 L, Rijavec M (2018) Hereditary angioedema due to C1-inhibitor deficiency in Macedonia: clinical characteristics, novel SERPING1 mutations and genetic factors modifying the clinical phenotype. Ann Med 50:269\u2013276","journal-title":"Ann Med"},{"key":"8836_CR10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000481987","volume":"174","author":"P Gianni","year":"2017","unstructured":"Gianni P, Loules G, Zamanakou M, Kompoti M, Csuka D, Psarros F, Magerl M et al (2017) Genetic determinants of C1 inhibitor deficiency angioedema age of onset. Int Arch Allergy Immunol 174:200\u2013204","journal-title":"Int Arch Allergy Immunol"},{"key":"8836_CR11","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jaci.2017.05.020","volume":"141","author":"V Bafunno","year":"2018","unstructured":"Bafunno V, Firinu D, D\u2019Apolito M, Cordisco G, Loffredo S, Leccese A, Bova M et al (2018) Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema. J Allergy Clin Immunol 141:1009\u20131017","journal-title":"J Allergy Clin Immunol"},{"key":"8836_CR12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/all.13270","volume":"73","author":"K Bork","year":"2018","unstructured":"Bork K, Wulff K, Steinm\u00fcller-Magin L, Braenne I, Staubach-Renz P, Witzke G, Hardt J (2018) Hereditary angioedema with a mutation in the plasminogen gene. Allergy 73:442\u2013450","journal-title":"Allergy"},{"key":"8836_CR13","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1111\/all.13869","volume":"74","author":"K Bork","year":"2019","unstructured":"Bork K, Wulff K, Rossmann H, Steinm\u00fcller-Magin L, Braenne I, Witzke G, Hardt J (2019) Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the N-terminal cleavage site of BK. Allergy 74:2479\u20132481","journal-title":"Allergy"},{"key":"8836_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/all.14454","author":"A Ariano","year":"2020","unstructured":"Ariano A, D\u2019Apolito M, Bova M, Bellanti F, Loffredo S, D\u2019Andrea G, Intrieri M et al (2020) A myoferlin gain-of-function variant associates with a new type of hereditary angioedema. Allergy\u00a075:2989-2992","journal-title":"Allergy"},{"key":"8836_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00887-3","author":"AE Germenis","year":"2020","unstructured":"Germenis AE, Vatsiou S, Csuka D, Zamanakou M, Farkas H (2020) Deep intronic SERPING1 gene variants: Ending one Odyssey and starting another? J Clin Immunol. https:\/\/doi.org\/10.1007\/s10875-020-00887-3","journal-title":"J Clin Immunol"},{"key":"8836_CR16","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00439-017-1809-4","volume":"136","author":"R Vaz-Drago","year":"2017","unstructured":"Vaz-Drago R, Cust\u00f3dio N, Carmo-Fonseca M (2017) Deep intronic mutations and human disease. Hum Genet 136:1093\u20131111","journal-title":"Hum Genet"},{"key":"8836_CR17","doi-asserted-by":"crossref","first-page":"102312","DOI":"10.1016\/j.jaut.2019.102312","volume":"104","author":"AE Germenis","year":"2019","unstructured":"Germenis AE, Cicardi M (2019) Driving towards Precision Medicine for angioedema without wheals. J Autoimmun 104:102312","journal-title":"J Autoimmun"},{"key":"8836_CR18","unstructured":"National Academies of Sciences, Engineering, and Medicine. Biomarker tests for molecularly targeted therapies: key to unlocking precision medicine. Washington, DC: The National Academies Press; 2016."},{"key":"8836_CR19","doi-asserted-by":"crossref","unstructured":"Berman JJ (2018) Precision Medicine and the reinvention of human disease. Academic Press.","DOI":"10.1016\/B978-0-12-814393-3.00008-1"},{"key":"8836_CR20","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/archinte.1917.00090060014002","volume":"20","author":"JR Crowder","year":"1917","unstructured":"Crowder JR, Crowder TR (1917) Five generations of angioneurotic edema. Arch Int Med 20:840","journal-title":"Arch Int Med"},{"key":"8836_CR21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12016-016-8543-x","volume":"51","author":"AE Germenis","year":"2016","unstructured":"Germenis AE, Speletas M (2016) Genetics of hereditary angioedema revisited. Clin Rev Allergy Immunol 51:170\u2013182","journal-title":"Clin Rev Allergy Immunol"},{"key":"8836_CR22","doi-asserted-by":"crossref","unstructured":"Ponard D, Gaboriaud C, Charignon D, Ghannam A, Wagenaar-Bos IGA, Roem D, L\u00f3pez-Lera A, et al. SERPING1 mutation update: Mutation spectrum and C1 Inhibitor phenotypes. Hum Mutat 41:38\u201357","DOI":"10.1002\/humu.23917"},{"key":"8836_CR23","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1067\/mai.2000.110471","volume":"106","author":"E Pappalardo","year":"2000","unstructured":"Pappalardo E, Cicardi M, Duponchel C, Carugati A, Choquet S, Agostoni A, Tosi M (2000) Frequent de novo mutations and exon deletions in the C1 inhibitor gene of patients with angioedema. J Allergy Clin Immunol 106:1147\u20131154","journal-title":"J Allergy Clin Immunol"},{"key":"8836_CR24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.gene.2018.05.029","volume":"667","author":"G Loules","year":"2018","unstructured":"Loules G, Zamanakou M, Parsopoulou F, Vatsiou S, Psarros F, Csuka D, Porebski G et al (2018) Targeted next-generation sequencing for the molecular diagnosis of hereditary angioedema due to C1-inhibitor deficiency. Gene 667:76\u201382","journal-title":"Gene"},{"issue":"20","key":"8836_CR25","first-page":"30003","volume":"S1323\u20138930","author":"S Vatsiou","year":"2020","unstructured":"Vatsiou S, Zamanakou M, Loules G, Psarros F, Parsopoulou F, Csuka D, Valerieva A et al (2020) A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiency. Allergol Int 69:443-449","journal-title":"Allergol Int"},{"key":"8836_CR26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10875-020-00753-2","volume":"40","author":"P Hujov\u00e1","year":"2020","unstructured":"Hujov\u00e1 P, Sou\u010dek P, Grodeck\u00e1 L, Grombi\u0159\u00edkov\u00e1 H, Rav\u010dukov\u00e1 B, Kukl\u00ednek P, Hakl R et al (2020) Deep intronic mutation in SERPING1 caused hereditary angioedema through pseudoexon activation. J Clin Immunol 40:435\u2013446","journal-title":"J Clin Immunol"},{"key":"8836_CR27","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jaci.2006.07.035","volume":"118","author":"A Blanch","year":"2006","unstructured":"Blanch A, Roche O, Urrutia I, Gamboa P, Font\u00e1n G, L\u00f3pez-Trascasa M (2006) First case of homozygous C1 inhibitor deficiency. J Allergy Clin Immunol 118:1330\u20131335","journal-title":"J Allergy Clin Immunol"},{"key":"8836_CR28","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jaci.2010.07.037","volume":"126","author":"A L\u00f3pez-Lera","year":"2010","unstructured":"L\u00f3pez-Lera A, Favier B, de la Cruz RM, Garrido S, Drouet C, L\u00f3pez-Trascasa M (2010) A new case of homozygous C1-inhibitor deficiency suggests a role for Arg378 in the control of kinin pathway activation. J Allergy Clin Immunol 126:1307\u20131310","journal-title":"J Allergy Clin Immunol"},{"key":"8836_CR29","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaci.2013.04.006","volume":"132","author":"V Bafunno","year":"2013","unstructured":"Bafunno V, Divella C, Sessa F, Tiscia GL, Castellano G, Gesualdo L, Margaglione M et al (2013) De novo homozygous mutation of the C1 inhibitor gene in a patient with hereditary angioedema. J Allergy Clin Immunol 132:748\u2013750","journal-title":"J Allergy Clin Immunol"},{"key":"8836_CR30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000492583","volume":"178","author":"N Mete G\u00f6kmen","year":"2019","unstructured":"Mete G\u00f6kmen N, G\u00fclbahar O, Onay H, Koc ZP, \u00d6zg\u00fcl S, K\u00f6se T, Gelincik A et al (2019) Deletions in SERPING1 lead to lower C1 inhibitor function: lower C1 inhibitor function can predict disease severity. Int Arch Allergy Immunol 178:50\u201359","journal-title":"Int Arch Allergy Immunol"},{"key":"8836_CR31","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/s41598-017-16667-w","volume":"8","author":"S Caccia","year":"2018","unstructured":"Caccia S, Suffritti C, Carzaniga T, Berardelli R, Berra S, Martorana V, Fra A et al (2018) Intermittent C1-inhibitor deficiency associated with recessive inheritance: functional and structural insight. Sci Rep 8:977","journal-title":"Sci Rep"},{"key":"8836_CR32","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/imcb.12362","volume":"98","author":"N Mete G\u00f6kmen","year":"2020","unstructured":"Mete G\u00f6kmen N, Rodr\u00edguez-Alcalde C, G\u00fclbahar O, Lopez-Trascasa M, Onay H, L\u00f3pez-Lera A (2020) Novel homozygous variants in the SERPING1 gene in two Turkish families with hereditary angioedema of recessive inheritance. Immunol Cell Biol 98:693\u2013699","journal-title":"Immunol Cell Biol"},{"key":"8836_CR33","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1172\/JCI112873","volume":"79","author":"M Cicardi","year":"1987","unstructured":"Cicardi M, Igarashi T, Rosen FS, Davis AE 3rd (1987) Molecular basis for the deficiency of complement 1 inhibitor in type I hereditary angioneurotic edema. J Clin Invest 79:698\u2013702","journal-title":"J Clin Invest"},{"key":"8836_CR34","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1172\/JCI117663","volume":"95","author":"E Verpy","year":"1995","unstructured":"Verpy E, Couture-Tosi E, Eldering E, Lopez-Trascasa M, Sp\u00e4th P, Meo T, Tosi M (1995) Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function. J Clin Invest 95:350\u2013359","journal-title":"J Clin Invest"},{"key":"8836_CR35","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1172\/JCI98869","volume":"129","author":"D Haslund","year":"2019","unstructured":"Haslund D, Ry\u00f8 LB, Majidi SS, Rose I, Skipper KA, Fryland T, Bohn AB et al (2019) Dominant-negative SERPING1 variants cause intracellular retention of C1 inhibitor in hereditary angioedema. J Clin Invest 129:388\u2013405","journal-title":"J Clin Invest"},{"key":"8836_CR36","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2133.2005.07048.x","volume":"154","author":"K Bork","year":"2006","unstructured":"Bork K, G\u00fcl D, Dewald G (2006) Hereditary angio-oedema with normal C1 inhibitor in a family with affected women and men. Br J Dermatol 154:542\u2013545","journal-title":"Br J Dermatol"},{"key":"8836_CR37","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI77139","volume":"125","author":"J Bj\u00f6rkqvist","year":"2015","unstructured":"Bj\u00f6rkqvist J, de Maat S, Lewandrowski U, Di Gennaro A, Oschatz C, Sch\u00f6nig K, N\u00f6then MM et al (2015) Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III. J Clin Invest 125:3132\u20133146","journal-title":"J Clin Invest"},{"key":"8836_CR38","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1182\/blood-2018-06-860270","volume":"133","author":"I Ivanov","year":"2019","unstructured":"Ivanov I, Matafonov A, Sun MF, Mohammed BM, Cheng Q, Dickeson SK, Kundu S et al (2019) A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain. Blood 133:1152\u20131163","journal-title":"Blood"},{"key":"8836_CR39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clim.2011.07.002","volume":"141","author":"K Bork","year":"2011","unstructured":"Bork K, Wulff K, Meinke P, Wagner N, Hardt J, Witzke G (2011) A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor. Clin Immunol 141:31\u201335","journal-title":"Clin Immunol"},{"key":"8836_CR40","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.anai.2017.04.014","volume":"118","author":"CL Veronez","year":"2017","unstructured":"Veronez CL, Serpa FS, Pesquero JB (2017) A rare mutation in the F12 gene in a patient with ACE inhibitor-induced angioedema. Ann Allergy Asthma Immunol 118:743\u2013745","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8836_CR41","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clim.2013.08.001","volume":"149","author":"N Kiss","year":"2013","unstructured":"Kiss N, Barab\u00e1s E, V\u00e1rnai K, Hal\u00e1sz A, Varga L\u00c1, Proh\u00e1szka Z, Farkas H, Szil\u00e1gyi \u00c1 (2013) Novel duplication in the F12 gene in a patient with recurrent angioedema. Clin Immunol 149:142\u2013145","journal-title":"Clin Immunol"},{"key":"8836_CR42","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/all.12648","volume":"70","author":"K Bork","year":"2015","unstructured":"Bork K, Wulff K, Witzke G, Hardt J (2015) Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations. Allergy 70:1004\u20131012","journal-title":"Allergy"},{"key":"8836_CR43","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/cea.13349","volume":"49","author":"M d'Apolito","year":"2019","unstructured":"d\u2019Apolito M, Santacroce R, Colia AL, Cordisco G, Maffione AB, Margaglione M (2019) Angiopoietin-1 haploinsufficiency affects the endothelial barrier and causes hereditary angioedema. Clin Exp Allergy 49:626\u2013635","journal-title":"Clin Exp Allergy"},{"key":"8836_CR44","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/all.13543","volume":"73","author":"A Belb\u00e9zier","year":"2018","unstructured":"Belb\u00e9zier A, Hardy G, Marlu R, Defendi F, Dumestre Perard C, Boccon-Gibod I, Launay D et al (2018) Plasminogen gene mutation with normal C1 inhibitor hereditary angioedema: three additional French families. Allergy 73:2237\u20132239","journal-title":"Allergy"},{"key":"8836_CR45","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1111\/all.13550","volume":"73","author":"H Yakushiji","year":"2018","unstructured":"Yakushiji H, Hashimura C, Fukuoka K, Kaji A, Miyahara H, Kaname S, Horiuchi T (2018) A missense mutation of the plasminogen gene in hereditary angioedema with normal C1 inhibitor in Japan. Allergy 73:2244\u20132247","journal-title":"Allergy"},{"key":"8836_CR46","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/all.13324","volume":"73","author":"AE Germenis","year":"2018","unstructured":"Germenis AE, Loules G, Zamanakou M, Psarros F, Gonz\u00e1lez-Quevedo T, Speletas M, Bork K et al (2018) On the pathogenicity of the plasminogen K330E mutation for hereditary angioedema. Allergy 73:1751\u20131753","journal-title":"Allergy"},{"key":"8836_CR47","doi-asserted-by":"crossref","unstructured":"Recke A, Massalme EG, Jappe U, Steinm\u00fcller-Magin L, Schmidt J, Hellenbroich Y, H\u00fcning I, et al (2019) Identification of the recently described plasminogen gene mutation p.Lys330Glu in a family from Northern Germany with hereditary angioedema. Clin Transl Allergy 14;9:9","DOI":"10.1186\/s13601-019-0247-x"},{"key":"8836_CR48","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2222.2009.03323.x","volume":"40","author":"T Hoover","year":"2010","unstructured":"Hoover T, Lippmann M, Grouzmann E, Marceau F, Herscu P (2010) Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors. Clin Exp Allergy 40:50\u201361","journal-title":"Clin Exp Allergy"},{"key":"8836_CR49","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/all.12380","volume":"69","author":"M Cicardi","year":"2014","unstructured":"Cicardi M, Aberer W, Banerji A, Bas M, Bernstein JA, Bork K, Caballero T, (HAWK under the patronage of EAACI), et al (2014) Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy 69:602\u2013616","journal-title":"Allergy"},{"key":"8836_CR50","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jaip.2018.04.022","volume":"6","author":"M Cicardi","year":"2018","unstructured":"Cicardi M, Zuraw BL (2018) Angioedema due to BK dysregulation. J Allergy Clin Immunol Pract 6:1132\u20131141","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8836_CR51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2500\/aap.2009.30.3188","volume":"30","author":"A Banerji","year":"2009","unstructured":"Banerji A, Sheffer AL (2009) The spectrum of chronic angioedema. Allergy Asthma Proc 30:11\u201316","journal-title":"Allergy Asthma Proc"},{"key":"8836_CR52","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s11906-003-0045-6","volume":"5","author":"A Zanchi","year":"2003","unstructured":"Zanchi A, Maillard M, Burnier M (2003) Recent clinical trials with omapatrilat: new developments. Curr Hypertens Rep 5:346\u2013352","journal-title":"Curr Hypertens Rep"},{"key":"8836_CR53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1081-1206(10)60860-5","volume":"98","author":"B Malde","year":"2007","unstructured":"Malde B, Regalado J, Greenberger PA (2007) Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Ann Allergy Asthma Immunol 98:57\u201363","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8836_CR54","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1751-7176.2010.00352.x","volume":"12","author":"WB White","year":"2010","unstructured":"White WB, Bresalier R, Kaplan AP, Palmer BF, Riddell RH, Lesogor A, Chang W et al (2010) Safety and tolerability of the direct renin inhibitor aliskiren: a pooled analysis of clinical experience in more than 12,000 patients with hypertension. J Clin Hypertens 12:765\u2013775","journal-title":"J Clin Hypertens"},{"key":"8836_CR55","doi-asserted-by":"crossref","unstructured":"Hermanrud T, Bygum A, Rasmussen ER (2017) Recurrent angioedema associated with pharmacological inhibition of dipeptidyl peptidase IV. BMJ Case Rep 2017:bcr2016217802","DOI":"10.1136\/bcr-2016-217802"},{"key":"8836_CR56","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1086\/496899","volume":"77","author":"QL Duan","year":"2005","unstructured":"Duan QL, Nikpoor B, Dube M-P, Molinaro G, Meijer IA, Dion P, Rochefort D (2005) A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. Am J Hum Genet 77:617\u2013626","journal-title":"Am J Hum Genet"},{"key":"8836_CR57","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/FPC.0b013e32833d3acb","volume":"20","author":"AV Woodard-Grice","year":"2010","unstructured":"Woodard-Grice AV, Lucisano AC, Byrd JB, Stone ER, Simmons WH, Brown NJ (2010) Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema. Pharmacogenet Genomics 20:532\u2013536","journal-title":"Pharmacogenet Genomics"},{"key":"8836_CR58","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/humu.21579","volume":"32","author":"AL Cilia La Corte","year":"2011","unstructured":"Cilia La Corte AL, Carter AM, Rice GI, Duan QL, Rouleau GA, Adam A, Grant PJ et al (2011) A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor-induced angioedema. Hum Mutat 32:1326\u20131331","journal-title":"Hum Mutat"},{"key":"8836_CR59","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/HYPERTENSIONAHA.107.102574","volume":"51","author":"GP Van Guilder","year":"2008","unstructured":"Van Guilder GP, Pretorius M, Luther JM, Byrd JB, Hill K, Gainer JV, Brown NJ (2008) BK type 2 receptor BE1 genotype influences BK-dependent vasodilation during angiotensin-converting enzyme inhibition. Hypertension 51:454\u2013459","journal-title":"Hypertension"},{"key":"8836_CR60","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/jch.12104","volume":"15","author":"RR Moholisa","year":"2013","unstructured":"Moholisa RR, Rayner BR, Patricia Owen E, Schwager SLU, Stark JS, Badri M, Cupido CL et al (2013) Association of B2 receptor polymorphisms and ACE activity with ACE inhibitor-induced angioedema in black and mixed-race South Africans. J Clin Hypertens 15:413\u2013419","journal-title":"J Clin Hypertens"},{"key":"8836_CR61","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/FPC.0b013e328363c137","volume":"23","author":"G Pare","year":"2013","unstructured":"Pare G, Kubo M, Byrd JB, McCarty CA, Woodard-Grice A, Teo KK, Anand SS et al (2013) Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedema. Pharmacogenet Genomics 23:470\u2013478","journal-title":"Pharmacogenet Genomics"},{"key":"8836_CR62","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/FPC.0000000000000264","volume":"27","author":"SH Mahmoudpour","year":"2017","unstructured":"Mahmoudpour SH, Veluchamy A, Siddiqui MK, Asselbergs FW, Souverein PC, de Keyser CE, Hofman A et al (2017) Meta-analysis of genome-wide association studies on the intolerance of angiotensin-converting enzyme inhibitors. Pharmacogenet Genomics 27:112\u2013119","journal-title":"Pharmacogenet Genomics"},{"key":"8836_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-020-0165-2","author":"ER Rasmussen","year":"2020","unstructured":"Rasmussen ER, Hallberg P, Baranova EV, Eriksson N, Karawajczyk M, Johansson C, Cavalli M et al (2020) Genome-wide association study of angioedema anduced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment. Pharmacogenomics J. https:\/\/doi.org\/10.1038\/s41397-020-0165-2","journal-title":"Pharmacogenomics J"},{"key":"8836_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1927","author":"C Maroteau","year":"2020","unstructured":"Maroteau C, Siddiqui MK, Veluchamy A, Carr F, White M, Cassidy AJ, Baranova EV et al (2020) Exome sequencing reveals common and rare variants in F5 associated with ACE inhibitor and angiotensin receptor blocker-induced angioedema. Clin pharmacol Ther. https:\/\/doi.org\/10.1002\/cpt.1927","journal-title":"Clin pharmacol Ther"},{"key":"8836_CR65","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaip.2019.10.004","volume":"8","author":"AE Germenis","year":"2020","unstructured":"Germenis AE, Margaglione M, Pesquero JB, Farkas H, Cichon S, Csuka D, Lera AL,: HAWK, et al (2020) International consensus on the use of genetics in the management of hereditary angioedema. J Allergy Clin Immunol Pract 8:901\u2013911","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8836_CR66","unstructured":"Betschel S, Badiou J, Binkley K, Borici-Mazi R, H\u00e9bert J, Kanani A, Keith P, et al (2019) The International\/Canadian hereditary angioedema guideline. Allergy Asthma Clin Immunol 15:72. Erratum in: Allergy Asthma Clin Immunol 2020;16:33"},{"key":"8836_CR67","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/cea.12293","volume":"44","author":"C Suffritti","year":"2014","unstructured":"Suffritti C, Zanichelli A, Maggioni L, Bonanni E, Cugno M, Cicardi M (2014) High-molecular-weight kininogen cleavage correlates with disease states in the BK-mediated angioedema due to hereditary C1-inhibitor deficiency. Clin Exp Allergy 44:1503\u20131514","journal-title":"Clin Exp Allergy"},{"key":"8836_CR68","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.molimm.2017.01.028","volume":"85","author":"D Charignon","year":"2017","unstructured":"Charignon D, Ghannam A, Ponard D, Drouet C (2017) Hereditary C1 inhibitor deficiency is associated with high spontaneous amidase activity. Mol Immunol 85:120\u2013122","journal-title":"Mol Immunol"},{"key":"8836_CR69","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/cea.13219","volume":"48","author":"ML Lara-Marquez","year":"2018","unstructured":"Lara-Marquez ML, Christiansen SC, Riedl MA, Herschbach J, Zuraw BL (2018) Threshold-stimulated kallikrein activity distinguishes BK- from histamine-mediated angioedema. Clin Exp Allergy 48:1429\u20131438","journal-title":"Clin Exp Allergy"},{"key":"8836_CR70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.molimm.2020.01.003","volume":"119","author":"B Larrauri","year":"2020","unstructured":"Larrauri B, Hester CG, Jiang H, Miletic VD, Malbran A, Bork K, Kaplan A et al (2020) sgp120 and the contact system in hereditary angioedema: a diagnostic tool in HAE with normal C1 inhibitor. Mol Immunol 119:27\u201334","journal-title":"Mol Immunol"},{"key":"8836_CR71","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fmed.2019.00028","volume":"6","author":"CL Veronez","year":"2019","unstructured":"Veronez CL, Aabom A, Martin RP, Filippelli-Silva R, Gon\u00e7alves RF, Nicolicht P, Mendes AR et al (2019) Genetic variation of kallikrein-kinin system and related genes in patients with hereditary angioedema. Front Med 6:28","journal-title":"Front Med"},{"key":"8836_CR72","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/all.13699","volume":"74","author":"LSM Maia","year":"2019","unstructured":"Maia LSM, Moreno AS, Ferriani MPL, Nunes FL, Ferraro MF, Dias MM, Roxo-Junior P et al (2019) Genotype-phenotype correlations in Brazilian patients with hereditary angioedema due to C1 inhibitor deficiency. Allergy 74:1013\u20131016","journal-title":"Allergy"},{"key":"8836_CR73","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/all.13001","volume":"72","author":"H Farkas","year":"2017","unstructured":"Farkas H, Martinez-Saguer I, Bork K, Bowen T, Craig T, Frank M, Germenis AE, Grumach AS, Luczay A, Varga L, Zanichelli A, HAWK, (2017) International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency. Allergy 72:300\u2013313","journal-title":"Allergy"},{"key":"8836_CR74","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/all.13582","volume":"74","author":"T Qiu","year":"2019","unstructured":"Qiu T, Chiuchiolo MJ, Whaley AS, Russo AR, Sondhi D, Kaminsky SM, Crystal RG et al (2019) Gene therapy for C1 esterase inhibitor deficiency in a murine model of hereditary angioedema. Allergy 74:1081\u20131089","journal-title":"Allergy"},{"key":"8836_CR75","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1261\/rna.068916.118","volume":"25","author":"J Liu","year":"2019","unstructured":"Liu J, Qin J, Borodovsky A, Racie T, Castoreno A, Schlegel M, Maier MA et al (2019) An investigational RNAi therapeutic targeting Factor XII (ALN-F12) for the treatment of hereditary angioedema. RNA 25:255\u2013263","journal-title":"RNA"},{"key":"8836_CR76","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJMoa1915035","volume":"383","author":"DM Cohn","year":"2020","unstructured":"Cohn DM, Viney NJ, Fijen LM, Schneider E, Alexander VJ, Xia S, Kaeser GE et al (2020) Antisense inhibition of prekallikrein to control hereditary angioedema. N Engl J Med 383:1242\u20131247","journal-title":"N Engl J Med"},{"key":"8836_CR77","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cca.2019.08.010","volume":"498","author":"MY Ang","year":"2019","unstructured":"Ang MY, Low TY, Lee PY, Wan Mohamad Nazarie WF, Guryev V, Jamal R (2019) Proteogenomics: from next-generation sequencing (NGS) and mass spectrometry-based proteomics to precision medicine. Clin Chim Acta 498:38\u201346","journal-title":"Clin Chim Acta"},{"key":"8836_CR78","doi-asserted-by":"crossref","unstructured":"Lumry WR. Hereditary angioedema: The economics of treatment of an orphan disease (2018) Front Med 5:22","DOI":"10.3389\/fmed.2018.00022"},{"key":"8836_CR79","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1398-9995.2010.02456.x","volume":"66","author":"A Bygum","year":"2011","unstructured":"Bygum A, Fagerberg CR, Ponard D, Monnier N, Lunardi J, Drouet C (2011) Mutational spectrum and phenotypes in Danish families with hereditary angioedema because of C1 inhibitor deficiency. Allergy 66:76\u201384","journal-title":"Allergy"},{"key":"8836_CR80","first-page":"134","volume":"99","author":"CC Lung","year":"1997","unstructured":"Lung CC, Chan EK, Zuraw BL (1997) Analysis of an exon 1 polymorphism of the B2 BK receptor gene and its transcript in normal subjects and patients with C1 inhibitor deficiency. J Allergy Clin Immunol 99:134\u2013146","journal-title":"J Allergy Clin Immunol"},{"key":"8836_CR81","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0198-8859(02)00397-X","volume":"63","author":"T Freiberger","year":"2002","unstructured":"Freiberger T, Vyskocilov\u00e1M KL, Kukl\u00ednek P, Krystufkov\u00e1 O, Lahodn\u00e1 M, Hanzl\u00edkov\u00e1 J et al (2002) Exon 1 polymorphism of the B2BKR gene does not influence the clinical status of patients with hereditary angioedema. Hum Immunol 63:492\u2013494","journal-title":"Hum Immunol"},{"key":"8836_CR82","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaip.2017.09.025","volume":"6","author":"CL Veronez","year":"2018","unstructured":"Veronez CL, Moreno AS, Constantino-Silva RN, Maia LSM, Ferriani MPL, Castro FFM, Valle SR et al (2018) Hereditary angioedema with normal C1 inhibitor and F12 mutations in 42 Brazilian families. J Allergy Clin Immunol Pract 6:1209-1216.e8","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8836_CR83","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW,: ACMG Laboratory Quality Assurance Committee, et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424","journal-title":"Genet Med"},{"key":"8836_CR84","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41436-018-0006-8","volume":"21","author":"Z Stark","year":"2019","unstructured":"Stark Z, Schofield D, Martyn M, Rynehart L, Shrestha R, Alam K, Lunke S et al (2019) Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness. Genet Med 21:173\u2013180","journal-title":"Genet Med"},{"key":"8836_CR85","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1515\/hsz-2015-0212","volume":"397","author":"CL Veronez","year":"2016","unstructured":"Veronez CL, da Silva ED, Lima Teixeira PV, Cagini N, Constantino-Silva RN, Grumach AS, Mansour E et al (2016) Genetic analysis of hereditary angioedema in a Brazilian family by targeted next generation sequencing. Biol Chem 397:315\u2013322","journal-title":"Biol Chem"},{"key":"8836_CR86","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3389\/fgene.2019.00900","volume":"10","author":"I Marcelino-Rodriguez","year":"2019","unstructured":"Marcelino-Rodriguez I, Callero A, Mendoza-Alvarez A, Perez-Rodriguez E, Barrios-Recio J, Garcia-Robaina JC, Flores C (2019) BK-mediated angioedema: an update of the genetic causes and the impact of genomics. Front Genet 10:900","journal-title":"Front Genet"},{"key":"8836_CR87","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2174\/1389202916666150317232930","volume":"16","author":"HL Blackburn","year":"2015","unstructured":"Blackburn HL, Schroeder B, Turner C, Shriver CD, Ellsworth DL, Ellsworth RE (2015) Management of incidental findings in the era of next-generation sequencing. Curr Genomics 16:159\u2013174","journal-title":"Curr Genomics"},{"key":"8836_CR88","doi-asserted-by":"crossref","unstructured":"Zanichelli A, Longhurst HJ, Maurer M, Bouillet L, Aberer W, Fabien V, Andresen I, et al; IOS Study Group (2016) Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting. Ann Allergy Asthma Immunol 117:394\u2013398","DOI":"10.1016\/j.anai.2016.08.014"},{"key":"8836_CR89","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/07853890.2016.1185144","volume":"48","author":"L Karad\u017ea-Lapi\u0107","year":"2016","unstructured":"Karad\u017ea-Lapi\u0107 L, Koro\u0161ec P, \u0160ilar M, Ko\u0161nik M, Cikojevi\u0107 D, Lozi\u0107 B, Rijavec M (2016) Frequent life-threatening laryngeal attacks in two Croatian families with hereditary angioedema due to C1 inhibitor deficiency harbouring a novel frameshift mutation in SERPING1. Ann Med 48:485\u2013491","journal-title":"Ann Med"},{"key":"8836_CR90","doi-asserted-by":"crossref","first-page":"e0142174","DOI":"10.1371\/journal.pone.0142174","volume":"10","author":"S Andrejevi\u0107","year":"2015","unstructured":"Andrejevi\u0107 S, Koro\u0161ec P, \u0160ilar M, Ko\u0161nik M, Mijanovi\u0107 R, Bona\u010di-Nikoli\u0107 B, Rijavec M (2015) Hereditary angioedema due to C1 inhibitor deficiency in Serbia: two novel mutations and evidence of genotype-phenotype association. PLoS ONE 10:e0142174","journal-title":"PLoS ONE"},{"key":"8836_CR91","doi-asserted-by":"crossref","first-page":"e56712","DOI":"10.1371\/journal.pone.0056712","volume":"8","author":"M Rijavec","year":"2013","unstructured":"Rijavec M, Koro\u0161ec P, \u0160ilar M, Zidarn M, Miljkovi\u0107 J, Ko\u0161nik M (2013) Hereditary angioedema nationwide study in Slovenia reveals four novel mutations in SERPING1 gene. PLoS ONE 8:e56712","journal-title":"PLoS ONE"},{"key":"8836_CR92","first-page":"6363787","volume":"2018","author":"D Moldovan","year":"2018","unstructured":"Moldovan D, Bara N, N\u0103d\u0103\u0219an V, G\u00e1bos G, Mih\u00e1ly E (2018) Consequences of misdiagnosed and mismanaged hereditary angioedema laryngeal attacks: an overview of cases from the Romanian registry. Case Rep Emerg Med 2018:6363787","journal-title":"Case Rep Emerg Med"},{"key":"8836_CR93","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/all.13667","volume":"74","author":"D Firinu","year":"2019","unstructured":"Firinu D, Loffredo S, Bova M, Cicardi M, Margaglione M, Del Giacco S (2019) The role of genetics in the current diagnostic workup of idiopathic non-histaminergic angioedema. Allergy 74:810\u2013812","journal-title":"Allergy"},{"key":"8836_CR94","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12016-016-8541-z","volume":"51","author":"MA Wu","year":"2016","unstructured":"Wu MA, Perego F, Zanichelli A, Cicardi M (2016) Angioedema phenotypes: disease expression and classification. Clin Rev Allergy Immunol 51:162\u2013169","journal-title":"Clin Rev Allergy Immunol"},{"key":"8836_CR95","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.iac.2013.07.002","volume":"33","author":"K Bork","year":"2013","unstructured":"Bork K (2013) Hereditary angioedema with normal C1 inhibitor. Immunol Allergy Clin North Am 33:457\u2013470","journal-title":"Immunol Allergy Clin North Am"},{"key":"8836_CR96","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41576-019-0127-1","volume":"20","author":"V Tam","year":"2019","unstructured":"Tam V, Patel N, Turcotte M, Boss\u00e9 Y, Par\u00e9 G, Meyre D (2019) Benefits and limitations of genome-wide association studies. Nat Rev Genet 20:467\u2013484","journal-title":"Nat Rev Genet"},{"key":"8836_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s10038-020-00845-2","author":"Y Momozawa","year":"2020","unstructured":"Momozawa Y, Mizukami K (2020) Unique roles of rare variants in the genetics of complex diseases in humans. J Hum Genet. https:\/\/doi.org\/10.1038\/s10038-020-00845-2","journal-title":"J Hum Genet"},{"key":"8836_CR98","doi-asserted-by":"crossref","first-page":"E987","DOI":"10.3390\/genes11090987","volume":"11","author":"S Amanat","year":"2020","unstructured":"Amanat S, Requena T, Lopez-Escamez JA (2020) A systematic review of extreme phenotype strategies to search for rare variants in genetic studies of complex disorders. Genes 11:E987","journal-title":"Genes"},{"key":"8836_CR99","doi-asserted-by":"crossref","first-page":"E3402","DOI":"10.3390\/jcm9113402","volume":"9","author":"G Loules","year":"2020","unstructured":"Loules G, Parsopoulou F, Zamanakou M, Csuka D, Bova M, Gonz\u00e1lez-Quevedo T, Psarros F et al (2020) Deciphering the genetics of primary angioedema with normal levels of C1 inhibitor. J Clin Med 9:E3402","journal-title":"J Clin Med"},{"key":"8836_CR100","first-page":"616","volume-title":"The Works of William Harvey","year":"1847","unstructured":"Harvey W, Letter to John Vlackveld. In: Willis R, (eds) (1847) The Works of William Harvey. London, Sydenham Society, p 616"},{"key":"8836_CR101","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ccc.2019.12.003","volume":"36","author":"KD Sack","year":"2020","unstructured":"Sack KD, Kellum JA, Parikh SM (2020) The Angiopoietin-Tie2 pathway in critical illness. Crit Care Clin 36:201\u2013216","journal-title":"Crit Care Clin"},{"key":"8836_CR102","doi-asserted-by":"crossref","first-page":"7180","DOI":"10.1111\/jcmm.14648","volume":"23","author":"W Zhu","year":"2019","unstructured":"Zhu W, Zhou B, Zhao C, Ba Z, Xu H, Yan X, Liu W et al (2019) Myoferlin, a multifunctional protein in normal cells, has novel and key roles in various cancers. J Cell Mol Med 23:7180\u20137189","journal-title":"J Cell Mol Med"},{"key":"8836_CR103","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1365-2133.2007.07778.x","volume":"156","author":"L Bouillet","year":"2007","unstructured":"Bouillet L, Ponard D, Rousset H, Cichon S, Drouet C (2007) A case of hereditary angio-oedema type III presenting with C1-inhibitor cleavage and a missense mutation in the F12 gene. J Dermatol 156:1063\u20131065","journal-title":"J Dermatol"},{"key":"8836_CR104","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jaci.2007.07.002","volume":"120","author":"L Martin","year":"2007","unstructured":"Martin L, Raison-Peyron N, N\u00f6then MM, Cichon S, Drouet C (2007) Hereditary angioedema with normal C1 inhibitor gene in a family with affected women and men is associated with the p.Thr328Lys mutation in the F12 gene. J Allergy Clin Immunol 120:975\u2013977","journal-title":"J Allergy Clin Immunol"},{"key":"8836_CR105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/00313020701716433","volume":"40","author":"CG Bell","year":"2008","unstructured":"Bell CG, Kwan E, Nolan RC, Baumgart KW (2008) First molecular confirmation of an Australian case of type III hereditary angioedema. Pathology 40:82\u201383","journal-title":"Pathology"},{"key":"8836_CR106","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1398-9995.2008.01764.x","volume":"64","author":"A Prieto","year":"2009","unstructured":"Prieto A, Tornero P, Rubio M, Fern\u00e1ndez-Cruz E, Rodriguez-Sainz C (2009) Missense mutation Thr309Lys in the coagulation factor XII gene in a Spanish family with hereditary angioedema type III. Allergy 64:284\u2013286","journal-title":"Allergy"},{"key":"8836_CR107","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jaci.2008.12.010","volume":"123","author":"QL Duan","year":"2009","unstructured":"Duan QL, Binkley K, Rouleau GA (2009) Genetic analysis of Factor XII and BK catabolic enzymes in a family with estrogen-dependent inherited angioedema. J Allergy Clin Immunol 123:906\u2013910","journal-title":"J Allergy Clin Immunol"},{"key":"8836_CR108","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jdermsci.2009.06.013","volume":"56","author":"N Nagy","year":"2009","unstructured":"Nagy N, Greaves MW, Tanaka A, McGrath JA, Grattan CE (2009) Recurrent European missense mutation in the F12 gene in a British family with type III hereditary angioedema. J Dermatol Sci 56:62\u201364","journal-title":"J Dermatol Sci"},{"key":"8836_CR109","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaci.2008.10.056","volume":"123","author":"F Hentges","year":"2009","unstructured":"Hentges F, Hilger C, Kohnen M, Gilson G (2009) Angioedema and estrogen-dependent angioedema with activation of the contact system. J Allergy Clin Immunol 123:262\u2013264","journal-title":"J Allergy Clin Immunol"},{"key":"8836_CR110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jaci.2009.03.038","volume":"124","author":"K Bork","year":"2009","unstructured":"Bork K, Wulff K, Hardt J, Witzke G, Staubach P (2009) Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy. J Allergy Clin Immunol 124:129\u2013134","journal-title":"J Allergy Clin Immunol"},{"key":"8836_CR111","doi-asserted-by":"crossref","first-page":"957507","DOI":"10.1155\/2010\/957507","volume":"2010","author":"O Picone","year":"2010","unstructured":"Picone O, Donnadieu A-C, Brivet FG, Boyer-Neumann C, Fr\u00e9meaux-Bacchi V, Frydman R (2010) Obstetrical complications and outcome in two families with hereditary angioedema due to mutation in the F12 gene. Obstet Gynecol Int 2010:957507","journal-title":"Obstet Gynecol Int"},{"key":"8836_CR112","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1398-9995.2010.02368.x","volume":"65","author":"V Vitrat-Hincky","year":"2010","unstructured":"Vitrat-Hincky V, Gompel A, Dumestre-Perard C, Boccon-Gibod I, Drouet C, Cesbron JY, Lunardi J et al (2010) Type III hereditary angio-oedema: clinical and biological features in a French cohort. Allergy 65:1331\u20131336","journal-title":"Allergy"},{"key":"8836_CR113","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1398-9995.2011.02562.x","volume":"66","author":"ML Baeza","year":"2011","unstructured":"Baeza ML, Rodr\u00edguez-Marco A, Prieto A, Rodr\u00edguez-Sainz C, Zubeldia JM, Rubio M (2011) Factor XII gene missense mutation Thr328Lys in an Arab family with hereditary angioedema type III. Allergy 66:981\u2013982","journal-title":"Allergy"},{"key":"8836_CR114","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.anai.2012.05.022","volume":"109","author":"C Marcos","year":"2012","unstructured":"Marcos C, L\u00f3pez Lera A, Varela S, Li\u00f1ares T, Alvarez-Eire MG, L\u00f3pez-Trascasa M (2012) Clinical, biochemical, and genetic characterization of type III hereditary angioedema in 13 Northwest Spanish families. Ann Allergy Asthma Immunol 109:195-200.e2","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8836_CR115","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1111\/hae.12519","volume":"20","author":"K Bork","year":"2014","unstructured":"Bork K, Wulff K, Hardt J, Witzke G, Lohse P (2014) Characterization of a partial exon 9\/intron 9 deletion in the coagulation factor XII gene (F12) detected in two Turkish families with hereditary angioedema and normal C1 inhibitor. Haemophilia 20:e372-375","journal-title":"Haemophilia"},{"key":"8836_CR116","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/joim.12304","volume":"277","author":"M Mansi","year":"2015","unstructured":"Mansi M, Zanichelli A, Coerezza A, Suffritti C, Wu MA, Vacchini R, Stieber C et al (2015) Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients. J Intern Med 277:585\u2013593","journal-title":"J Intern Med"},{"key":"8836_CR117","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.clim.2015.02.013","volume":"157","author":"D Firinu","year":"2015","unstructured":"Firinu D, Valeria Bafunno V, Vecchione G, Barca MP, Manconi PE, Santacroce R, Margaglione M et al (2015) Characterization of patients with angioedema without wheals: the importance of F12 gene screening. Clin Immunol 157:239\u2013248","journal-title":"Clin Immunol"},{"key":"8836_CR118","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/all.12769","volume":"71","author":"AS Grumach","year":"2016","unstructured":"Grumach AS, Stieber C, Veronez CL, Cagini N, Constantino-Silva RN, Cordeiro E, N\u00f6then MM et al (2016) Homozygosity for a factor XII mutation in one female and one male patient with hereditary angio-oedema. Allergy 71:119\u2013123","journal-title":"Allergy"},{"key":"8836_CR119","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/cei.12820","volume":"185","author":"A Deroux","year":"2016","unstructured":"Deroux A, Boccon-Gibod I, Fain O, Pralong P, Ollivier Y, Pagnier A, Djenouhat K et al (2016) Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema. Clin Exp Immunol 185:332\u2013337","journal-title":"Clin Exp Immunol"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08836-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-021-08836-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08836-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T23:56:48Z","timestamp":1724371008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-021-08836-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":119,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["8836"],"URL":"https:\/\/doi.org\/10.1007\/s12016-021-08836-7","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,28]]},"assertion":[{"value":"7 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standard"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}